News
The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a ...
Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...
The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's drug to treat a type of bladder cancer, providing ...
The U.S. Food and Drug Administration has approved Moderna’s (MRNA) RSV vaccine, mRESVIA (mRNA-1345), for preventing lower respiratory tract disease in adults aged 18 to 59 who are at higher risk for ...
WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) says it plans to use artificial ...
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...
The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a welcome win.
2d
Medpage Today on MSNFDA Officials Lay Out Vision for AgencyThe new FDA commissioner and Center for Biologics Evaluation and Research (CBER) director laid out their vision for the ...
The FDA approved intravesical mitomycin in non–muscle-invasive bladder cancer as an nonsurgical alternative to transurethral ...
By Lori Solomon HealthDay ReporterWEDNESDAY, June 11, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
The federal government plans to develop a new definition of ultraprocessed foods, a wide-ranging group of snacks, meals and ...
AI is slowly permeating all corners of the federal government, including the Food and Drug Administration, where, according ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results